Our latest blog post, Medical Affairs Must Pivot Toward Payers, describes the most recent Scientific Commercialization research – “How Can Medical Affairs Optimize Market Access Impact?” Through a series of interviews with US-based Market Access and Medical Affairs leaders representing a variety of global biopharmaceutical companies, Scientific Commercialization solicited input on the top challenges and opportunities for Medical Affairs interactions with Market Access and the payer community.
Follow the title link in the paragraph above to read the complete post.